Immune cell profiles of metastatic HER2-positive breast cancer patients according to the sites of metastasis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-7217
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Immune cell profiles of metastatic HER2-positive breast cancer patients according to the sites of metastasis ; volume:191 ; number:2 ; day:24 ; month:11 ; year:2021 ; pages:443-450 ; date:1.2022
Breast cancer research and treatment ; 191, Heft 2 (24.11.2021), 443-450, 1.2022
- Urheber
-
Honkanen, Tiia J.
Luukkainen, Milla E. K.
Tikkanen, Antti
Karihtala, Peeter
Mäkinen, Markus
Väyrynen, Juha P.
Koivunen, Jussi P.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10549-021-06447-6
- URN
-
urn:nbn:de:101:1-2022043008514876115840
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Honkanen, Tiia J.
- Luukkainen, Milla E. K.
- Tikkanen, Antti
- Karihtala, Peeter
- Mäkinen, Markus
- Väyrynen, Juha P.
- Koivunen, Jussi P.
- SpringerLink (Online service)
Ähnliche Objekte (12)
How We Treat HER2-Positive Metastatic Breast Cancer
ASCO 2019: highlights in HER2-positive metastatic breast cancer
ASCO 2018: highlights in HER2-positive metastatic breast cancer
Genomic characteristics of trastuzumab-resistant Her2-positive metastatic breast cancer
New Systemic Therapy Strategies for HER2-Positive Metastatic Breast Carcinoma
SIRT6 promotes metastasis and relapse in HER2-positive breast cancer
Appendicitis caused by the metastasis of HER2-positive breast cancer
Current Standards and Future Outlooks in Metastatic Her2-Positive Breast Cancer
Complete pathologic response of HER2-positive breast cancer liver metastasis with dual Anti-HER2 antagonism
Prognostic factors of brain metastasis and survival among HER2-positive metastatic breast cancer patients: a systematic literature review
New Therapeutic Strategies in Advanced Nonoperable or Metastatic HER2-positive Breast Cancer
Austrian treatment algorithms in HER2-positive metastatic breast cancer: a 2022 update
How We Treat HER2-Positive Metastatic Breast Cancer
ASCO 2019: highlights in HER2-positive metastatic breast cancer
ASCO 2018: highlights in HER2-positive metastatic breast cancer
Genomic characteristics of trastuzumab-resistant Her2-positive metastatic breast cancer
New Systemic Therapy Strategies for HER2-Positive Metastatic Breast Carcinoma
SIRT6 promotes metastasis and relapse in HER2-positive breast cancer
Appendicitis caused by the metastasis of HER2-positive breast cancer
Current Standards and Future Outlooks in Metastatic Her2-Positive Breast Cancer
Complete pathologic response of HER2-positive breast cancer liver metastasis with dual Anti-HER2 antagonism
Prognostic factors of brain metastasis and survival among HER2-positive metastatic breast cancer patients: a systematic literature review
New Therapeutic Strategies in Advanced Nonoperable or Metastatic HER2-positive Breast Cancer
Austrian treatment algorithms in HER2-positive metastatic breast cancer: a 2022 update
How We Treat HER2-Positive Metastatic Breast Cancer
ASCO 2019: highlights in HER2-positive metastatic breast cancer
ASCO 2018: highlights in HER2-positive metastatic breast cancer
Genomic characteristics of trastuzumab-resistant Her2-positive metastatic breast cancer
New Systemic Therapy Strategies for HER2-Positive Metastatic Breast Carcinoma
SIRT6 promotes metastasis and relapse in HER2-positive breast cancer
Appendicitis caused by the metastasis of HER2-positive breast cancer
Current Standards and Future Outlooks in Metastatic Her2-Positive Breast Cancer
Complete pathologic response of HER2-positive breast cancer liver metastasis with dual Anti-HER2 antagonism
Prognostic factors of brain metastasis and survival among HER2-positive metastatic breast cancer patients: a systematic literature review
New Therapeutic Strategies in Advanced Nonoperable or Metastatic HER2-positive Breast Cancer